Skip to content

Effect of different doses of dexmedetomidine nasal spray on stress response and postoperative delirium in elderly patients undergoing orthopedic surgery

Effect of different doses of dexmedetomidine nasal spray on stress response and postoperative delirium in elderly patients undergoing orthopedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095748
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb fractures

Interventions

A Group:All elderly patients entered the pre-anesthesia room 30 minutes in advance, sprayed placebo normal saline from the nasal cavity, sprayed 1 spray into each nostril, stayed for about 30s, a tota
B Grop:All elderly patients entered the pre-anesthesia room 30 minutes in advance, sprayed dexmedetomidine from the nasal cavity, sprayed 1 spray into each nostril on both sides, stayed for about 30s,
C Group:All elderly patients entered the pre-anesthesia room 30 minutes in advance, sprayed dexmedetomidine from the nasal cavity, sprayed 1 spray into each nostril on each side, stayed for about 30 s
D Grop:All elderly patients entered the pre-anesthesia room 30 minutes in advance, sprayed dexmedetomidine from the nasal cavity, sprayed 1 spray into each nostril on both sides, stayed for about 30s,

Sponsors

Hainan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: Elderly patients aged 65-75 years who have undergone major orthopaedic surgery; No contraindications to related medications; Preoperative family members sign the informed consent form for the trial.

Exclusion criteria

Exclusion criteria: Sinus bradycardia (<50 beats/min), atrioventricular block, sick sinus syndrome; allergy to narcotic drugs; Prior use of immunosuppressants and recent chemoradiotherapy; Current use of non-steroidal anti-inflammatory drugs or steroids, angiotensin-converting enzyme inhibitors, or bronchodilators; hepatic and renal insufficiency; epilepsy and related mental and cognitive dysfunction, long-term stress stimuli or psychological disorders; history of alcoholism, analgesic dependence, and long-term use of sedatives; Severe asthma, severe emphysema, severe bronchitis, severe chronic obstructive pulmonary disease, cardiac insufficiency.

Design outcomes

Primary

MeasureTime frame
Delirium conditions;

Secondary

MeasureTime frame
Procalcitonin (PCT);Interleukin-6;Serum amyloid A (SAA);Intraoperative dose of sufentanil;Occurrence of intraoperative hypoxemia (SPO2<90%);Time to postoperative extubation;Incidence of nausea and vomiting at 24 hours postoperatively;Stress response;

Countries

China

Contacts

Public ContactLin Jinyu

Hainan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

846902967@qq.com+86 186 8965 5057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026